- Experiment 1: Comparisons of Vaccines
- Experiment 2: Assessment of higher doses of Recombinant DNA spike (S) protein vaccine (SV)
- Experiment 3: Mouse and Vaccine Specificity

Experiments Conducted in Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus

- Experiment 1: Tricking the Immune System
- Experiment 2: Harnessing vesicles
- Experiment 3: Nanoplasmids
- Experiment 4: Insect Cells


Latin American Scientists Join the Coronavirus Vaccine Race

- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- Latin American Scientists Join the Coronavirus Vaccine Race

Northwestern University

University of Michigan - Ann Arbor

- Vaccine Development
- Antibody immune response
- Epidemiology and transmission dynamics 

Focuses of Epidemiological studies on SARS-CoV

- Public Library of Science
- Nature Magazine
- Vaccine
- Cell
- New England Journal of Medicine

Vaccine Development for SARS-CoV References by Journal 

Articles on SARS-CoV Vaccine Development

A study showed that SARS neutralizing antibodies can successfully block SARS-CoV-2 entry into target cells in vitro, suggesting that the two viruses possess a cross-protective epitope and have similar immune protection against reinfection

SARS neutralizing antibodies and SARS-CoV-2


- PLOS ONE
- THE LANCET
- CDC
- New England Journal of Medicine (NEJM)
- Journal of Infectious Diseases
- Journal of Immunology
- JAMA Network
- MedRxiv

Antibody Immune Response for SARS-CoV References by Journal/ Source

- Philosophical transactions of the Royal Society of London. Series B, Biological sciences
- The Lancet

Epidemiology and Transmission Dynamics of SARS-CoV References by Journal

- The agent of SARS
- The first wave
- The second wave 
- Superspreader events
- Environment of SARS
- Transmission dynamics 

Learn Before

Related

Learn After